MedTrace Logo

Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?

NCT00175760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-04-12

No results posted yet for this study

Summary

This study is to see if a high response to the TTG screening test for celiac disease is as accurate as the current method of diagnosing celiac disease which entails a general anesthetic and upper endoscopy to obtain biopsies of the small intestine. If the screening blood test is highly accurate, then some patients that are being evaluated for celiac disease may not require an upper GI endoscopy and can be treated more quickly. If they respond to the therapy then they will be deemed to have celiac disease.

Conditions

Interventions

PROCEDURE

Diagnosis of Celiac Disease

During GI endoscopy a minimum of 4 small intestinal biopsies will be taken from all subjects and controls.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Dr. Collin Barker · University of British Columbia

Eligibility

Min Age
2 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2006-10-31
Completion
2006-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00175760 on ClinicalTrials.gov